BDTX director granted 40,000 stock options
Black Diamond Therapeutics director Kapil Dhingra received a grant of stock options for 40,000 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Black Diamond Therapeutics director Kapil Dhingra received a grant of stock options for 40,000 shares of common stock. The options have an exercise price of $1.71 per share and expire on June 25, 2036. All 40,000 options are reported as held directly following this award.
According to the grant terms, the options will vest and become exercisable in full on the earlier of June 26, 2027 or the company’s next annual meeting of stockholders, provided Dhingra continues to serve through the vesting date. This is a compensation-related award, not an open-market purchase.
Insider Trade Summary
Grant/Award: 40,000 shares
Grant/Award
1 txn
Insider
Dhingra Kapil
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 40,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 40,000 contracts (Direct)
Footnotes (1)
- F1. The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 26, 2027 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date.
Key Figures
Option grant size: 40,000 options
Exercise price: $1.71 per share
Underlying shares: 40,000 shares
+3 more
6 metrics
Option grant size
40,000 options
Stock Option (Right to Buy) awarded to director
Exercise price
$1.71 per share
Exercise price of stock options
Underlying shares
40,000 shares
Common stock underlying the option award
Post-transaction derivative holdings
40,000 options
Total derivative securities following transaction
Vesting date trigger
June 26, 2027
Full vesting or earlier at next annual meeting
Expiration date
June 25, 2036
Option expiration if not exercised
Key Terms
Stock Option (Right to Buy), derivative security, exercise price, vesting, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
derivative security financial
"transaction_type: derivative"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
exercise price financial
"conversion_or_exercise_price: 1.7100"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"shares subject to this option shall vest and become exercisable in full"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: 2036-06-25T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Black Diamond Therapeutics (BDTX) director Kapil Dhingra receive in this Form 4?
Kapil Dhingra received a stock option grant for 40,000 shares of Black Diamond Therapeutics common stock. The award is compensation-related, reported as a derivative security, and gives the right to buy shares at a fixed exercise price in the future.
What is the exercise price of Kapil Dhingra’s new BDTX stock options?
The stock options have an exercise price of $1.71 per share. This means Dhingra can buy up to 40,000 shares of Black Diamond Therapeutics common stock at $1.71 if and when the options vest and are exercised.
When do Kapil Dhingra’s Black Diamond Therapeutics options vest?
The options vest in full on the earlier of June 26, 2027 or Black Diamond Therapeutics’ next annual stockholder meeting. Vesting is conditioned on Dhingra’s continued service with the company through that vesting date as disclosed in the footnote.
How many Black Diamond Therapeutics options does Kapil Dhingra hold after this grant?
After this transaction, the Form 4 shows Dhingra holding 40,000 stock options. These options relate to 40,000 underlying shares of common stock and represent his position following the award reported in this specific filing.
When do Kapil Dhingra’s Black Diamond Therapeutics options expire?
The options expire on June 25, 2036 if not exercised earlier. After that expiration date, any unexercised options become worthless, so exercise must occur after vesting and before the stated expiration to obtain common shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates